Cumulative numbers and percentages of participants stating that they preferred drugs in the first and second interviews
| Five-year coronary risk | Social class | Total | |||
|---|---|---|---|---|---|
| I & II | III | IV & V | Not known | ||
| First interview | |||||
| 3% | 23 (37.1%) | 55 (58.5%) | 33 (71.7%) | 1 (100%) | 112 (55.2%) |
| 6% | 27 (43.5%) | 58 (61.7%) | 34 (73.9%) | 1 (100%) | 120 (59.1%) |
| 10% | 33 (53.2%) | 67 (71.3%) | 37 (80.4%) | 1 (100%) | 138 (68.0%) |
| 15% | 38 (61.3%) | 73 (77.7%) | 40 (87.0%) | 1 (100%) | 152 (74.9%) |
| 20% | 43 (69.4%) | 77 (81.9%) | 43 (93.5%) | 1 (100%) | 164 (80.8%) |
| 30% | 44 (71.0%) | 83 (88.3%) | 44 (95.7%) | 1 (100%) | 172 (84.7%) |
| Declined at 30% | 62 (100%) | 94 (100%) | 46 (100%) | 1 (100%) | 203 (100%) |
| Second interview | |||||
| 3% | 17 (30.4%) | 38 (44.7%) | 21 (53.8%) | 1 (100%) | 77 (42.5%) |
| 6% | 23 (41.1%) | 45 (52.9%) | 24 (61.5%) | 1 (100%) | 93 (51.4%) |
| 10% | 29 (51.8%) | 55 (64.7%) | 31 (79.5%) | 1 (100%) | 116 (64.1%) |
| 15% | 36 (64.3%) | 66 (77.6%) | 36 (92.3%) | 1 (100%) | 139 (76.8%) |
| 20% | 41 (73.2%) | 71 (83.5%) | 37 (94.9%) | 1 (100%) | 150 (82.9%) |
| 30% | 41 (73.2%) | 76 (89.4%) | 38 (97.4%) | 1 (100%) | 156 (86.2%) |
| Declined at 30% | 56 (100%) | 85 (100%) | 39 (100%) | 1 (100%) | 181 (100%) |